BPA Call HHSN263200800124B-75N98021F00007

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $750,000 firm fixed-price contract to Silver Lake Research Corporation, a small business located in Irwindale, California, under SBIR Topic 118 focused on developing reagents for immunologic analysis of non-mammalian and underrepresented mammalian models. The contract, which carries a total small business set-aside designation, was awarded on September 1, 2023, with an ultimate completion date of August 31, 2026....

This purchase order contract from the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awards Integrated Laboratory Systems, LLC $1,056,867.90 to provide histopathology services in support of 18 efficacy studies and options for 12 additional studies involving viruses with pandemic potential. Per the original solicitation, the contractor will prepare hematoxylin and eosin stained microscope slides from...

This is a definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a corporate entity tax-exempt non-profit organization. The contract, valued at $2,900,275.00, is for AIDS research (basic) work and does not have a set-aside designation. Southern Research Institute, doing business as Southern Research, has a history of providing drug discovery, development, and...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to Southern Research Institute, a corporate non-profit organization. The $452,600 contract is for the delivery of a "COMPREHENSIVE PANEL FOR VIRUSES" and is categorized as a Delivery Order under the NIAID's In Vitro Antimicrobial Assessments 2011-2018 contract vehicle. The contract has a firm fixed price and does not...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Leica Biosystems Imaging, Inc. The $245,707 firm fixed-price purchase order provides consolidated equipment for the NIAID intramural research program for influenza studies. The deliverables include a ScanScope XT digital slide scanner, a ScanScope FL fluorescence whole-slide scanner, slide analysis tools, software, installation,...

Sigmovir Biosystems, Inc. was awarded a $591,222 cost-plus-fixed-fee delivery order against the National Institute of Allergy and Infectious Diseases' (NIAID) Preclinical Models of Infectious Diseases master IDIQ contract for the period 2017 to 2024. The delivery order, set to be completed by September 2023, provides base task order funding under award number 1700028I in support of NIAID's pre-clinical models of infectious diseases program. Specifically, Sigmovir Biosystems will utilize the...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $332,878 delivery order to Pharmacology Discovery Services Taiwan, LTD under the NIAID Preclinical Models of Infectious Diseases 2017-2024 master IDIQ. This cost-plus-award-fee contract will provide pre-clinical models of infectious diseases to support research efforts at NIAID through September 1, 2021. As part of its mission to conduct and support research on infectious, immunologic, and...

This is a $256,922.43 firm-fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Saint Louis University, a private university, for the development of mouse models for orthopoxviruses. The contract has no set-aside designation, indicating it was competed on a full and open basis. This contract is a task order issued under NIAID's larger "Animal Models of Infectious Diseases 2010-2017" indefinite delivery...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a cost-plus-fixed-fee delivery order valued at $139.9 million to Leidos Biomedical Research Inc. on August 31, 2025, with an ultimate completion date of August 30, 2027. This NIAID Fiscal Years 2026-27 Operational Task Order, performed at the contractor's Frederick, Maryland facility, represents a continuation of Leidos Biomedical Research Inc.'s role as a Federally Funded Research and Development Center (FFRDC) supporting...